NeuroBionics is an MIT spinout commercializing hair-thin bioelectric fibers made from carbon nanotubes that can be routed through brain blood vessels using a stent-like procedure to deliver neuromodulation. The fibers are powered by a standard implantable battery shaped like an AirPod case designed to last five to ten years and aim to avoid the open‑brain drilling required for traditional deep brain stimulation. Founders MJ Antonini (CEO) and Nicky Driscoll (CTO) built the company from roughly a decade of MIT fiber research and secured three patents that give MIT a small ownership stake. The startup says carbon nanotubes may be cheaper, longer‑lasting, reduce tissue damage, and improve MRI compatibility versus platinum or iridium oxide electrodes. NeuroBionics closed $5 million in funding led by Dolby Family Ventures and will use the capital to complete its clinical device and pursue preclinical safety and efficacy testing in pigs. If preclinical work succeeds, the company plans to seek FDA review and an investigational device exemption to begin first‑in‑human early feasibility studies, with a possible market timeline mentioned around 2030.

Total raised

$5M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2025